Related references
Note: Only part of the references are listed.Vasoactive intestinal polypeptide evokes only a minimal headache in healthy volunteers
J. M. Hansen et al.
CEPHALALGIA (2006)
Location and function of VPAC(1), VPAC(2) and NPR-C receptors in VIP-induced vasodilation of porcine basilar arteries
S Grant et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2006)
Unitary hypothesis for multiple triggers of the pain and strain of migraine
R Burstein et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2005)
A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate
SK Afridi et al.
BRAIN (2005)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Noxious chemical stimulation of rat facial mucosa increases intracranial blood flow through a trigemino-parasympathetic reflex - an experimental model for vascular dysfunctions in cluster headache
R Gottselig et al.
CEPHALALGIA (2004)
Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache
L Edvinsson
CEPHALALGIA (2004)
Glyceryl trinitrate triggers premonitory symptoms in migraineurs
SK Afridi et al.
PAIN (2004)
Passage of VIP/PACAP/secretin family across the blood-brain barrier: Therapeutic effects
D Dogrukol-Ak et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release
G Juhasz et al.
PAIN (2003)
2003 Wolff Award: Possible parasympathetic contributions to peripheral and central sensitization during migraine
D Yarnitsky et al.
HEADACHE (2003)
Premonitory symptoms in migraine - An electronic diary study
NJ Giffin et al.
NEUROLOGY (2003)
Passage of vasoactive intestinal peptide across the blood-brain barrier
D Dogrukol-Ak et al.
PEPTIDES (2003)
The effect of nitric oxide synthase inhibition on histamine induced headache and arterial dilatation in migraineurs
LH Lassen et al.
CEPHALALGIA (2003)
Migraine can be induced by sildenafil without changes in middle cerebral artery diameter
C Kruuse et al.
BRAIN (2003)
Unilateral cranial autonomic symptoms in migraine
P Barbanti et al.
CEPHALALGIA (2002)
Nuclear factor-κB as a molecular target for migraine therapy
U Reuter et al.
ANNALS OF NEUROLOGY (2002)
Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia
M Knutsson et al.
NEUROREPORT (2002)
CGRP may play a causative role in migraine
LH Lassen et al.
CEPHALALGIA (2002)
Drug therapy: Migraine - Current understanding and treatment.
PJ Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Delayed inflammation in rat meninges: implications for migraine pathophysiology
U Reuter et al.
BRAIN (2001)
Origin and co-localization of nitric oxide synthase, CGRP, PACAP, and VIP in the cerebral circulation of the rat
L Edvinsson et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2001)
Meningeal nociception: Electrophysiological studies related to headache and referred pain
K Messlinger et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2001)
Tbe development of cutaneous allodynia during a migraine attack - Clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine
R Burstein et al.
BRAIN (2000)
Immunohistochemical localization of the VIP1 receptor (VPAC1R) in rat cerebral blood vessels:: Relation to PACAP and VIP containing nerves
J Fahrenkrug et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2000)
Dipyridamole dilates large cerebral arteries concomitant to headache induction in healthy subjects
C Kruuse et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2000)
Share Paper
